Standard BioTools Inc. (LAB) Balance Sheet
As of 2026-06-30 (10-Q), Standard BioTools Inc. (LAB) reported total assets of $627.2M, total liabilities of $87.2M and shareholders' equity of $540.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $270.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LABStandard BioTools Inc.Follow LAB — free
—
Price chart with a free account
- Market cap
- 237.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Jan 18 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13.6 | 58.6 | 35.3 | 33.7 | 29.1 | 35.0 | 58.1 | 95.4 | 21.7 | 68.5 | 28.5 | 81.3 | 51.7 | 166.7 | 120.9 | 270.0 | |
| Short-term investments | 39.9 | 21.4 | 49.1 | 81.6 | 65.9 | 24.4 | 5.1 | 0.0 | 37.0 | 0.0 | 0.0 | 84.5 | 63.2 | 126.1 | 66.7 | 206.7 | |
| Receivables | 9.3 | 12.9 | 10.6 | 22.4 | 25.5 | 14.6 | 15.0 | 16.7 | 19.0 | 25.4 | 18.3 | 17.3 | 19.7 | 14.7 | 13.4 | 15.7 | |
| Inventory | 6.0 | 7.2 | 8.1 | 16.0 | 17.9 | 20.1 | 15.1 | 13.0 | 13.9 | 19.7 | 20.8 | 21.5 | 20.5 | 20.7 | 20.0 | 17.1 | |
| Current assets | 70.0 | 101.2 | 104.6 | 155.9 | 144.1 | 96.7 | 95.0 | 127.1 | 96.1 | 117.7 | 72.1 | 208.8 | 158.2 | 375.9 | 454.3 | 516.9 | |
| Total assets | 79.3 | 113.7 | 116.9 | 407.6 | 370.1 | 306.4 | 287.7 | 303.6 | 264.8 | 324.8 | 275.2 | 390.3 | 323.1 | 612.3 | 567.8 | 627.2 | |
| Current liabilities | 20.2 | 11.6 | 18.0 | 29.4 | 30.1 | 29.5 | 33.5 | 37.6 | 32.8 | 54.2 | 49.6 | 43.4 | 109.3 | 65.9 | 108.3 | 56.8 | |
| Long-term debt | 1.2 | 0.0 | — | — | — | — | — | — | — | 0.0 | 10.0 | 64.9 | 63.5 | 0.3 | — | — | |
| Short-term debt | 8.9 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 22.4 | 13.1 | 20.5 | 257.1 | 255.1 | 253.2 | 256.4 | 231.5 | 111.2 | 185.7 | 180.6 | 160.5 | 159.9 | 140.6 | 143.5 | 87.2 | |
| Shareholders' equity | 56.9 | 100.7 | 96.4 | 150.4 | 114.9 | 53.2 | 31.3 | 72.1 | 153.6 | 139.1 | 94.6 | -81.5 | -148.1 | 471.7 | 424.3 | 540.0 |
USD millions · SEC XBRL
Standard BioTools Inc. — questions
- How much cash does Standard BioTools Inc. have?
- $270.0M in cash and cash equivalents as of 2026-06-30.
- What are Standard BioTools Inc.'s total assets?
- $627.2M as of 2026-06-30.
- What is Standard BioTools Inc.'s shareholders' equity?
- $540.0M as of 2026-06-30.
Every figure on this page comes from Standard BioTools Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.